Carbamazepine Capsule, Extended Release — FDA Drug Shortage

To Be Discontinued — Takeda Pharmaceuticals USA Inc.

The FDA lists a drug shortage record for Carbamazepine Capsule, Extended Release (capsule, extended release) from Takeda Pharmaceuticals USA Inc. with status To Be Discontinued. The shortage was first posted on Dec 19, 2025.

Shortage details

Status
To Be Discontinued
Company
Takeda Pharmaceuticals USA Inc.
Package NDC
54092-171-12
Dosage Form
Capsule, Extended Release
Presentation
Carbatrol, Capsule, Extended Release, 100 mg (NDC 54092-171-12)
Initial Posting
Dec 19, 2025

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.